Research Funding

  • August 10, 2017 - July 31, 2020 - PROSPECTIVE LONGITUDINAL STUDY OF IWITH SCREEN FAILURES SECONDARY TO HISTOPATHOLOGY, Principal Investigator. Sponsor: NIH/NIDDK, Sponsor Award ID: R01DK114180
  • June 1, 2014 - May 31, 2019 - Donor-Alloantigen-Reactive Regulatory T Cell Therapy in Liver Transplantation, Principal Investigator. Sponsor: NIH/NIAID, Sponsor Award ID: U01AI110658
  • February 1, 2013 - January 31, 2018 - Polyclonal Tregs to Promote Tolerance in Pediatric Liver Transplant Recipients, Principal Investigator. Sponsor: NIH/NIAID, Sponsor Award ID: U01AI104347
  • July 27, 2012 - June 30, 2017 - Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients, Principal Investigator. Sponsor: NIH/NIAID, Sponsor Award ID: U01AI100807


Harvard and Radcliffe Colleges, Cambridge, MA, B.A., 1979-1982, Chemistry
Trinity College, Cambridge University, Cambridge, England, Ph.D., 1982-1985, Molecular Biology
Stanford University School of Medicine, Stanford, CA, M.D., 1985-1990, Medicine

Honors & Awards

  • 1979
    National Merit Scholarship
  • 1979
    Harvard and Radcliffe National Scholarship
  • 1981
    Phi Beta Kappa
  • 1981
    Marshall Scholarship
  • 1982
    DeLancey Scholarship
  • 1986
    EMBO (European Molecular Biology Organization) Fellowship
  • 1995
    Sandoz Transplant Research Fellowship, American Society of Transplant Surgeons
  • 1997
    Young Investigator Award, American Society of Transplant Surgeons
  • 1999
    American College of Surgeons Faculty Research Fellowship Award
  • 2004
    Young Investigator Award, American Society of Transplant Surgeons
  • 2004
    Vanguard Prize, American Society of Transplant Surgeons

Selected Publications

  1. Dixon W, Feng S, Gardner J Transplantation From Older Donors: Can Senolytics Turn Back the Clock?  View on PubMed
  2. Syed SM, Gardner J, Roll G, Webber A, Mehta N, Shoji J, Adelmann D, Niemann C, Braun HJ, Mello A, Yao F, Posselt A, Kang SM, Hirose R, Roberts J, Feng S, Ascher N, Stock P, Freise C COVID-19 and Abdominal Transplant: A Stepwise Approach to Practice During Pandemic Conditions.  View on PubMed
  3. Feng S, Bucuvalas JC, Mazariegos GV, Magee JC, Sanchez-Fueyo A, Spain KM, Lesniak A, Kanaparthi S, Perito E, Venkat VL, Burrell BE, Alonso EM, Bridges ND, Doo E, Gupta NA, Himes RW, Ikle D, Jackson AM, Lobritto SJ, Jose Lozano J, Martinez M, Ng VL, Rand EB, Sherker AH, Sundaram SS, Turmelle YP, Wood-Trageser M, Demetris AJ Efficacy and Safety of Immunosuppression Withdrawal in Pediatric Liver Transplant Recipients: Moving Towards Personalized Management.  View on PubMed
  4. Roll GR, Webber AB, Gae DH, Laszik Z, Tavakol M, Mayen L, Cunniffe K, Syed S, Hirose R, Freise C, Feng S, Roberts JP, Ascher NL, Stock PG, Rajalingam R A Virtual Crossmatch-based Strategy Facilitates Sharing of Deceased Donor Kidneys for Highly Sensitized Recipients.  View on PubMed
  5. Thiessen C, Wisel SA, Yamaguchi S, Dietch ZC, Feng S, Freise CE Rapid Modification of Workflows and Fellow Staffing at a Single Transplant Center to Address the COVID-19 Crisis.  View on PubMed
  6. Roll GR, Posselt AM, Freise J, Baird J, Syed S, Mo Kang S, Hirose R, Szot GL, Zarinsefat A, Feng S, Worner G, Sarwal M, Stock PG Long-term follow-up of beta cell replacement therapy in 10 HIV-infected patients with renal failure secondary to type 1 diabetes mellitus.  View on PubMed
  7. Perito ER, Martinez M, Turmelle YP, Mason K, Spain KM, Bucuvalas JC, Feng S Posttransplant biopsy risk for stable long-term pediatric liver transplant recipients: 451 percutaneous biopsies from two multicenter immunosuppression withdrawal trials.  View on PubMed
  8. Feng S, Bucuvalas J Reply.  View on PubMed
  9. Feng S, Bucuvalas JC, Demetris AJ, Burrell BE, Spain KM, Kanaparthi S, Magee JC, Ikle D, Lesniak A, Lozano JJ, Alonso EM, Bray RA, Bridges NE, Doo E, Gebel HM, Gupta NA, Himes RW, Jackson AM, Lobritto SJ, Mazariegos GV, Ng VL, Rand EB, Sherker AH, Sundaram S, Turmelle YP, Sanchez-Fueyo A Evidence of Chronic Allograft Injury in Liver Biopsies From Long-term Pediatric Recipients of Liver Transplants.  View on PubMed
  10. Lai JC, Covinsky KE, Dodge JL, Boscardin WJ, Segev DL, Roberts JP, Feng S Reply.  View on PubMed
  11. Lai JC, Segev DL, McCulloch CE, Covinsky KE, Dodge JL, Feng S Physical frailty after liver transplantation.  View on PubMed
  12. Lai JC, Covinsky KE, McCulloch CE, Feng S The Liver Frailty Index Improves Mortality Prediction of the Subjective Clinician Assessment in Patients With Cirrhosis.  View on PubMed
  13. Feng S, Bucuvalas J Tolerance after liver transplantation: Where are we?  View on PubMed
  14. Feng S Living donor liver transplantation in high Model for End-Stage Liver Disease score patients.  View on PubMed
  15. McLin VA, Allen U, Boyer O, Bucuvalas J, Colledan M, Cuturi MC, d'Antiga L, Debray D, Dezsofi A, Goyet JV, Dhawan A, Durmaz O, Falk C, Feng S, Fischler B, Franchi-Abella S, Frauca E, Ganschow R, Gottschalk S, Hadzic N, Hierro L, Horslen S, Hubscher S, Karam V, Kelly D, Maecker-Kolhoff B, Mazariegos G, McKiernan P, Melk A, Nobili V, Ozgenç F, Reding R, Sciveres M, Sharif K, Socha P, Toso C, Vajro P, Verma A, Wildhaber BE, Baumann U Early and Late Factors Impacting Patient and Graft Outcome in Pediatric Liver Transplantation: Summary of an ESPGHAN Monothematic Conference.  View on PubMed
  16. Lai JC, Covinsky KE, Dodge JL, Boscardin WJ, Segev DL, Roberts JP, Feng S Development of a novel frailty index to predict mortality in patients with end-stage liver disease.  View on PubMed
  17. Feng S Optimizing Graft Survival by Pretreatment of the Donor.  View on PubMed
  18. Chandran S, Feng S Current status of tolerance in kidney transplantation.  View on PubMed
  19. Wang CW, Feng S, Covinsky KE, Hayssen H, Zhou LQ, Yeh BM, Lai JC A Comparison of Muscle Function, Mass, and Quality in Liver Transplant Candidates: Results From the Functional Assessment in Liver Transplantation Study.  View on PubMed
  20. Feng S, Demetris AJ, Spain KM, Kanaparthi S, Burrell BE, Ekong UD, Alonso EM, Rosenthal P, Turka LA, Ikle D, Tchao NK Five-year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R.  View on PubMed

Go to UCSF Profiles, powered by CTSI